Waystar bundles four agentic AI tools into one launch
On August 26, 2026, revenue cycle vendor Waystar announced four new agentic AI solutions under its AltitudeAI platform: Autonomous Claim Resolution, Conversational Revenue Cycle Intelligence, Agentic Clinical Documentation, and Agentic Patient Financial Engagement. The announcement leans on scale to make its case — Waystar says its platform processes more than 7.5 billion healthcare transactions a year, touching roughly 60% of U.S. patients and over $2.4 trillion in annual gross claims.
For medical coders and RCM teams, the announcement matters less for its size than for what it bundles together. Denial resolution, documentation review, and coding-adjacent analytics are being sold as a single agentic layer rather than three separate point tools — a packaging choice that says as much about where the market is heading as any individual feature.
The fourth piece, Agentic Patient Financial Engagement, is aimed at patient-facing billing communication rather than coding itself — an AI concierge meant to explain what a patient owes and why. It’s a reminder that “agentic AI in revenue cycle” now spans everything from back-office code correction to front-of-house collections, under one marketing umbrella and, increasingly, one platform contract.
Autonomous Claim Resolution targets the denials that were always going to get paid
The most coding-relevant piece is Autonomous Claim Resolution, which is built around a specific inefficiency: Waystar’s own data shows that approximately 70% of initially denied claims are eventually paid anyway, after manual rework. The agentic tool is designed to interpret payer responses, apply payer-specific logic, and automatically resubmit eligible claims without a person re-keying the correction.
Why this is a coding problem, not just a billing problem
Denial resubmission has always depended on correct coding the second time around — a missing modifier, an unspecified diagnosis code, or a mismatched place-of-service value is often the reason a clean claim denies in the first place. Automating the resubmission step only works if the underlying code selection is also correct, which means these tools live right at the boundary between coding accuracy and billing operations. Coding teams evaluating vendors like this should ask specifically how code-level corrections are surfaced for review, not just whether the claim eventually gets paid.
Agentic Clinical Documentation narrows the CDI review window
The second solution, Agentic Clinical Documentation, is pitched as a CDI aid rather than a coding decision-maker. Waystar says it can analyze approximately 30,000 data points within a medical record in seconds, organizing evidence for a specialist’s review, with early use reducing review time by approximately 25%. Waystar’s Conversational Revenue Cycle Intelligence tool, a natural-language analytics layer, reportedly cut time spent on data analysis by up to 75% for early adopters.
That framing — the AI organizes and surfaces, a specialist still decides — is the same pattern showing up across the CDI vendor landscape this year. It’s a meaningful distinction for compliance purposes: a tool that assembles evidence for a coder or CDI specialist to review carries different audit exposure than one that assigns codes outright.
What this signals for coding and compliance teams
Taken together, the launch points to a few things worth tracking regardless of which vendor a health system uses:
- Denial management, CDI, and coding-adjacent analytics are converging into single agentic platforms rather than staying as separate best-of-breed tools.
- Vendors are increasingly citing specific efficiency percentages (25%, 70%, 75%) rather than vague productivity claims — expect procurement teams to start asking for the methodology behind those numbers.
- The “agent organizes, human decides” pattern is becoming the default compliance posture for documentation tools, even as claim resubmission tools push closer to full automation.
- Scale claims (transaction volume, patient coverage) are being used as a proxy for model reliability — a data point worth weighing separately from actual coding accuracy in any given specialty.
What to watch next
The near-term test for tools like these isn’t the launch announcement — it’s how they perform under audit scrutiny once claims volume scales past early adopters. Coding and compliance leads should ask any vendor making similar claims for a breakdown of where automation ends and human review begins, and for audit trail documentation that shows exactly which corrections were AI-suggested versus AI-applied. Read the full announcement from Waystar’s August 26 press release for the complete list of claimed results.
Questions worth asking before adopting a bundled agentic platform
Bundled launches like this one make it easy to evaluate a vendor on the size of the platform rather than the accuracy of any one component. Coding leadership should be able to get a straight answer on three things before signing on: what percentage of the claimed efficiency gain comes from the coding-accuracy improvement versus faster manual workflows; whether the audit trail distinguishes AI-suggested corrections from AI-applied ones at the individual claim level; and whether the vendor’s accuracy figures have been validated against an independent sample rather than the vendor’s own early-adopter cohort. None of those questions are answered in the press release itself, which is exactly why they’re worth asking directly.
Platforms that combine agentic automation with clear, auditable human checkpoints are the ones likely to hold up as scrutiny increases — which is the same principle behind Medikode’s automated medical coding platform, built to keep coders in the loop on every AI-assisted code suggestion rather than replacing their judgment.